[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
October 3, 2007

Omitted Financial Disclosure in: Decreased β-Amyloid

JAMA. 2007;298(13):1516. doi:10.1001/jama.298.13.1516-b

Omitted Financial Disclosure: In the Original Contribution entitled “Decreased β-Amyloid1-42 and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease” published in the April 23/30, 2003, issue of JAMA (2003;289[16]:2094-2103), the following financial disclosure should have been published. Dr Sunderland reports having received honoraria from and/or consulting for Quintiles, Pfizer, Abbott, Alza, Novartis, Lundbeck, AstraZeneca, and CNS.